David Jennings

David Jennings has served as the Chief Financial Officer and Secretary since July of 2016. Prior to joining Cerus, Mr. Jennings served as CFO for Dysis Medical Limited from April 2013 to July 2016. Between 2008 and 2013 Mr. Jennings worked as a portfolio financial officer and consultant for a number of technology and medical technology businesses, raising both equity and debt capital and managing growth companies through to exit.

Mr. Jennings is a qualified Chartered Accountant with 30 years’ experience across a number of industrial sectors. He has served 8 years as CFO for Tissue Science Laboratories from December 1999 to May 2008, taking the company from early stage, through a number of private financing rounds, completing an IPO onto the AIM market and seeing the Company through to successful trade sale to Covidien. Mr. Jennings has career equity, debt and exit financings of over $150 million. Mr. Jennings has a BA (hons) degree, majoring in History, from Lancaster University in the UK.